US Patent 9776995 Bicyclic sulfonamide compounds as sodium channel inhibitors
Patent 9776995 was granted and assigned to Amgen on October, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9776995 Bicyclic sulfonamide compounds as sodium channel inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.